5Bruix J,Gastells A,Montanya X, et al. Phase Ⅱstudy of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials.Hepatology,1994,20:643-650.
6Loewe C,Thurher SA,Hittmair CK, et al. Hepatic catheter embolization lipiodol and glue in the treatment of advanced hepatocellular carcinoma. Cardiovasc Intervent Radiol,1999,22(Suppl 2):172.
7Ikeda K, Kumada H, Saitoh S, et al. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma:an analysis by the Cox proportional hazard model. Cancer,1991,68:2150-2154.
8Winkelbauer FW,Niederle B,Pietschmann F, et al. Hepatic artery embolotherapy of hepatic metastases from carcinoid tumors: value of using a mixture of cyanoacrylate and ethiodized oil.AJR,1995,165:323-327.
9Berghammer P, Pfeffel F,Winkelbauer F,et al. Arterial hepatic embolization of unresectable hepatocellular carcinoma using a cyanoacylate/lipiodol mixture. Cardiovasc Intervent Radiol, 1998, 21: 214-218.
10Kamada K,Nakanishi T,Kitamoto M,et al. Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrocholoride emulsion. J Vasc Interv Radiol, 2001,12:847- 854.
